The last week of SPACs was packed with market activity including deals, IPOs, and Lawsuits.
The SPAC bubble burst has led to the market being flooded with penny stocks.
Also, a serial sponsor upsizes its IPO for its next SPAC, a SPAC is taking a drug development firm public, and a medical testing firm comes under scrutiny due to mounting losses and lawsuits from customers.
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.